Beneficial effects of pre-treatment with vitamin A on cardiac and pulmonary functions in endotoxaemic pigs

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 5, 1996, Pages 538-548

  Eriksson, M ^a   Lundkvist, K ^a   Drott, P ^a   Saldeen, T ^a   Eriksson, O ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Clin Chem Luleå Boden Hosp   (Sweden)

Author keywords

Animal model; ARDS; Cardiac; Endotoxin; Permeability; Prostaglandins; Pulmonary; Septic shock; Vitamin A

Indexed keywords

RETINOL;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOTOXEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLIC ACIDOSIS; NONHUMAN; OXYGEN SUPPLY; PRIORITY JOURNAL; SEPTIC SHOCK; SWINE;

EID: 0029899853     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb04485.x     Document Type: Article

References (29)

1. Modig J. Adult respiratory distress syndrome. Comp Path Bull 1989: 21: 2-4.
2. Borg T, Alvfors A, Gerdin B, Modig J. A porcine model of early respiratory distress syndrome induced by endotoxemia. Acta Anaesthesiol Scand 1985: 29: 814-830.
3. Cain S, Curtis S. Experimental models of pathologic oxygen supply dependency. Crit Care Med 1991: 19: 603-612.
4. Schumacker P, Cain S. The concept of critical oxygen delivery. Intensive Care Med 1987: 13: 1376-1386.
5. Bryan-Brown C. Gas transport and delivery. Uptake, solubility, and distribution of gases. In: Shoemaker WC, Thompson W, Holbrook P, eds. Textbook of critical care. Philadelphia: W B Saunders, 1984: 210-218.
6. Drott P, Meurling S, Kulander L, Eriksson Ö. Effects of vitamin A on endotoxemia in rats. Eur J Surg 1991: 157: 565-569.
7. Hatchigan E, Santos J, Broitman S, Vitale J. Vitamin A supplementation improves macrophage function and bacterial clearence during experimental Salmonella infection (42888). Proc Soc Exp Biol Med 1989: 191: 47-54.
8. Ellrodt AG. Sepsis and septic shock. Emerg Med Clin North Am 1986: 4: 809-841.
9. Sable CA, Wispelwey B. Pharmacologie interventions aimed at preventing the biologic effects of endotoxin. Infect Dis Clin North Am 1991: 5: 883-898.
10. Halevy O, Sklan D. Inhibition of arachidonic acid oxidation by β-carotene, vitamin A and α-tocopherol. Biochim Biophys Acta 1987: 918: 304-307.
11. Saldeen P, Esquivel C, Björck C, Bergqvist D, Saldeen T. Thromboxane production in umbilical vein grafts. Thromb Res 1984: 33: 259-267.
12. Tucker A, McMurtry F, Reeves J, Alexander A, Will D, Grover R. Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude. Am J Physiol 1975: 228: 762-767.
13. Kuriyama T, Wagner W. Collateral ventilation may protect against high-altitude pulmonary hypertension. J Appl Physiol 1981: 51: 1251-1256.
14. Shoemaker WC, Appel PL, Bland RD. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988: 94: 1176-1186.
15. Vincent J-L. Oxygen tranport in severe sepsis. Acta Anaesthesiol Scand 1993: 37: 29-31.
16. Haupt MT, Gilbert EM, Colson RW. Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Respir Dis 1985: 131: 912-916.
17. McGuire GP, Pearl RG. Trauma and sepsis. In: Grande CM, ed. Textbook of trauma, anaesthesia and critical care. International Trauma, Anaesthesia and Critical Care Society. St. Louis: Mosby, 1988: 865-882.
18. Maier RV, Ulevitch RJ. The response of isolated rabbit hepatic macrophages (H-Mo) to lipopolysaccharide (LPS). Circ Shock 1981: 8: 165-181.
19. Mathison JC, Ulevitch RJ. The clearance, tissue distribution and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979: 123: 2133-2143.
20. McCuskey RS, Urbaschek R, McCuskey PA, Urbaschek B. In vivo microscopic observations of the responses of Kupffer cells and the hepatic microcirculation to Mycobacterium bovis BCG alone and in combination with endotoxin. Infect Immun 1983: 42: 362-367.
21. Nolan JP. Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1981: 1: 458-465.
22. Young LS. Gram-negative sepsis. In: Mandell C, Douglas J, Bennett J, eds. Principles and practice of infectiouses diseases. New York: Wiley Medical Books, 1979: 452-475.
23. Vincent J-L. Severe sepsis and septic shock: Are we making progress? Int J Intens Care 1994: 1: 41.
24. Blomhoff HK, Smeland EB, Erikstein B, Rasmussen AM, Skrede B, Skjönsberg C, Blomhoff R. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem 1992: 167: 23988-23992.
25. Sauter C, Wolfsberger C. Interferon in human serum after injection of endotoxin. Lancet 1980: 2: 852-853.
26. Eden E, Turino GM. Interleukin-1 secretion by human alveolar macrophages stimulated with endotoxin is augmented by recombinant immune (gamma) interferon. Am Rev Respir Dis 1986: 133: 455-460.
27. Carman J, Colleen H. Abnormal regulation of ifn-g secretion in vitamin A deficiency. J Immunol 1991: 147: 1247-1252.
28. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986: 163: 1433-1450.
29. Bower H, Cerra F, Bershadsky B, Licari J, Hoyt D, Jensen G, et al. Early enterai administration of a formula (Impact®) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, trial. Crit Care Med 1995: 23: 436-449.